Gh Research Plc (GHRS)

07:32 AM

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

07:32 AM

07:00 AM

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - Yahoo

07:00 AM

May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025

May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025

May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025

May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025

May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025

May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025

May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025

May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025

May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025

May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025

May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025

Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025

Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025

Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025

Apr 16, 2025

(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 16, 2025

Mar 31, 2025

(GHRS) Proactive Strategies - news.stocktradersdaily.com

Mar 31, 2025

Mar 20, 2025

How To Trade (GHRS) - news.stocktradersdaily.com

Mar 20, 2025

Mar 20, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025

Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025

Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 11, 2025

GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater

Mar 11, 2025

Mar 10, 2025

How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com

Mar 10, 2025

Mar 10, 2025

GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World

Mar 10, 2025

Mar 10, 2025

GH Research PLC (NASDAQ:GHRS) Receives $30.67 Consensus PT from Brokerages - Defense World

Mar 10, 2025

Mar 08, 2025

Q1 Earnings Forecast for GH Research Issued By HC Wainwright - Defense World

Mar 08, 2025

Mar 07, 2025

RBC Capital Initiates Coverage of GH Research (GHRS) with Outperform Recommendation - Nasdaq

Mar 07, 2025

Mar 07, 2025

FY2029 EPS Estimates for GH Research Lifted by HC Wainwright - Defense World

Mar 07, 2025

Mar 07, 2025

GH Research initiated with an Outperform at RBC Capital - TipRanks

Mar 07, 2025

Mar 05, 2025

GH Research PLC Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 05, 2025

Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock - Investing.com

Mar 05, 2025

Mar 04, 2025

Postpartum Depression Pipeline Revealed in 2025 Forecast Report Featuring GH Research, Reunion Neuroscience, Lipocine, and Brii Biosciences - GlobeNewswire Inc.

Mar 04, 2025

Mar 03, 2025

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - MSN

Mar 03, 2025

Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025

Mar 01, 2025

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025

Mar 01, 2025

GH Research (GHRS) to Release Quarterly Earnings on Thursday - MarketBeat

Mar 01, 2025

Feb 28, 2025

GH Research (NASDAQ:GHRS) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025

Feb 28, 2025

H.C. Wainwright maintains buy on GH Research stock, $40 target - MSN

Feb 28, 2025

Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Psychedelic: GH Research, Compass Pathways report earnings results - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

GH Research (NASDAQ:GHRS) Given New $32.00 Price Target at Stifel Nicolaus - MarketBeat

Feb 28, 2025

Feb 27, 2025

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Feb 27, 2025

Feb 27, 2025

Form F-3 GH Research PLC - StreetInsider.com

Feb 27, 2025

Feb 27, 2025

GH Research Reports 2024 Financial Results and Clinical Progress - TipRanks

Feb 27, 2025

Feb 27, 2025

Can GH Research's Depression Drug Change Treatment Paradigms? Phase 2b Shows Striking 57.5% Remission Rate - StockTitan

Feb 27, 2025

Feb 27, 2025

GH Research PLC Provides Business Updates and Financial Results, Advances Clinical Trials for GH001 in Treatment-Resistant Depression - Nasdaq

Feb 27, 2025

Feb 26, 2025

Stifel raises GH Research stock target to $32 on strong trial data - Investing.com

Feb 26, 2025

Feb 26, 2025

Stifel raises GH Research stock target to $32 on strong trial data By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 24, 2025

GH Research PLC (GHRS): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey

Feb 24, 2025